Alzamend Neuro, Inc.

ALZN·NASDAQ·$1.15Share Price as of 11/2·$4MMarket Cap as of 11/2

Financials

10-QQ1 ended 07/31/2609/10/26 10-KFY 202607/22/26 10-QQ3 ended 01/31/2603/11/26 10-QQ2 ended 10/31/2512/09/25 10-QQ1 ended 07/31/2509/10/25

Disclosures

8-KCurrent report09/29/26 8-KCurrent report08/03/26 8-KCurrent report07/21/26 8-KCurrent report04/17/26 8-KCurrent report03/20/26

Prospectuses and Registrations

S-1Registration statement (IPO)08/21/26 424B5Prospectus supplement03/06/26 424B3Prospectus04/09/25 S-1/ARegistration statement (amended)03/27/25 S-3Shelf registration03/13/25

Proxies

PRE 14APreliminary proxy08/28/26 DEF 14ADefinitive proxy02/26/26 DEFA14AAdditional proxy materials02/26/26 PRE 14APreliminary proxy02/09/26 DEFA14AAdditional proxy materials03/19/25

Ownership

Form 4Insider transaction08/31/26 4/AInsider transaction (amended)08/31/26 4/AInsider transaction (amended)08/31/26 Form 4Insider transaction08/04/26 Form 5Annual insider statement08/04/26

Other

RWRegistration withdrawal10/09/26 EFFECTRequest for effectiveness04/08/25 CORRESPCorrespondence with the SEC04/04/25 UPLOADLetter from the SEC03/21/25 NT 10-KLate filing notification (10-K)07/30/24